Trial Profile
A prospective, observational, single centre study to evaluate the efficacy of tolvaptan in decompensated heart failure Japanese patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2016 New trial record